1. The importance of mitochondrial folate enzymes in human colorectal cancer
    Masaaki Miyo et al, 2017, Oncology Reports CrossRef
  2. Correlation of IDH1 and B7 H3 expression with prognosis of CRC patients
    Jingyi Wu et al, 2018, European Journal of Surgical Oncology CrossRef
  3. Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
    Elisa Bergaggio et al, 2019, Cancers CrossRef
  4. Elevated d -2-hydroxyglutarate during colitis drives progression to colorectal cancer
    Jie Han et al, 2018, Proceedings of the National Academy of Sciences CrossRef
  5. Absence of IDH mutation in colorectal cancers with microsatellite instability
    David Tougeron et al, 2016, Digestive and Liver Disease CrossRef
  6. Methylosystem for Cancer Sieging Strategy
    Shotaro Tatekawa et al, 2021, Cancers CrossRef
  7. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
    Francesca Petralia et al, 2020, Cell CrossRef
  8. Tumorigenesis and Metabolism Disorder
    Fan Yang et al, 2019, Virus Infection and Tumorigenesis CrossRef
  9. Pancreatic Cancer Research beyond DNA Mutations
    Hiromichi Sato et al, 2022, Biomolecules CrossRef
  10. IDH1 and IDH2 Mutations in Colorectal Cancers
    Jialing Huang et al, 2021, American Journal of Clinical Pathology CrossRef
  11. Significant epitranscriptomes in heterogeneous cancer
    Masamitsu Konno et al, 2019, Cancer Science CrossRef
  12. Gene expression changes of isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 affect carcinogenesis and survival probability
    Esra BULUT ATALAY, 2024, Gümüşhane Üniversitesi Fen Bilimleri Enstitüsü Dergisi CrossRef
  13. The elevated D-2-hydroxyglutarate level found as a characteristic metabolic change of colon cancer in both in vitro and in vivo models
    Esra Bulut Atalay et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  14. Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer
    Masaaki Miyo et al, 2016, Scientific Reports CrossRef
  15. Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases
    Hiroyuki Minemura et al, 2021, Breast Cancer CrossRef